Mylicon Children Simethicone Meteorism Drops 30 ml

WARNINGS
Do not exceed the recommended dose.
PHARMACOTHERAPEUTIC CATEGORY
Other drugs for intestinal functional disorders.
STORAGE
There are no particular storage conditions.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients. Generally contraindicated in pregnancy.
NAME
MYLICON
EXCIPIENTS
Citric acid monohydrate; sodium citrate; methyl hydroxypropylcellulose; carboxypolymethylene; saccharin; sodium benzoate; sorbic acid; sodium bicarbonate; essence of raspberry; concentrated essence of vanilla; purified water.
SIDE EFFECTS
No undesirable effects due to the drug were highlighted.
PREGNANCY AND BREASTFEEDING
Pregnancy. There are no adequate data on use in pregnant women, therefore it should not be used in pregnancy unless there is a real need and after a risk / benefit assessment by the physician. Feeding time. It is not known whether simethicone is excreted in human milk. The excretion of simethicone into breast milk has not been studied in animals. The decision whether to continue / discontinue breastfeeding or to continue / discontinue simethicone therapy should be made taking into account the benefit of breastfeeding for the infant and the benefit of simethicone therapy for the woman.
INDICATIONS
Symptomatic treatment of gastrointestinal bloating and aerophagia in the infant and child.
INTERACTIONS
No incompatibilities with other drugs are known, nor have they been reported.
DOSAGE
Infants and children: 20 drops (= 0.6 ml), 2-4 times a day, preferably after meals or otherwise according to medical prescription. Shake well before use.
ACTIVE PRINCIPLES
1 ml contains: simethicone (activated dimethylpolysiloxane) 66.6 mg.